The 36-month beta value for YCBD is at 2.16. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for YCBD is 5.54M, and currently, shorts hold a 8.56% of that float. The average trading volume for YCBD on February 05, 2025 was 1.81M shares.
YCBD) stock’s latest price update
cbdMD Inc (AMEX: YCBD)’s stock price has dropped by -6.10 in relation to previous closing price of 0.61. Nevertheless, the company has seen a loss of -3.23% in its stock price over the last five trading days. newsfilecorp.com reported 2025-01-15 that Charlotte, North Carolina–(Newsfile Corp. – January 15, 2025) – cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), a leading and highly trusted CBD company known for its flagship brands cbdMD and Paw CBD, as well as its innovative functional mushroom brand ATRx Labs, today announced that the Company has fully satisfied the accrued interest and principal associated with its Senior Secured Convertible Notes. As of January 14, 2025, there are 6,262,833 shares of the Company’s common stock issued and outstanding.
YCBD’s Market Performance
cbdMD Inc (YCBD) has experienced a -3.23% fall in stock performance for the past week, with a 38.31% rise in the past month, and a 12.27% rise in the past quarter. The volatility ratio for the week is 12.99%, and the volatility levels for the past 30 days are at 24.10% for YCBD. The simple moving average for the past 20 days is 5.29% for YCBD’s stock, with a 1.72% simple moving average for the past 200 days.
YCBD Trading at 20.47% from the 50-Day Moving Average
After a stumble in the market that brought YCBD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -57.27% of loss for the given period.
Volatility was left at 24.10%, however, over the last 30 days, the volatility rate increased by 12.99%, as shares sank -0.85% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +27.19% upper at present.
During the last 5 trading sessions, YCBD fell by -3.23%, which changed the moving average for the period of 200-days by -37.76% in comparison to the 20-day moving average, which settled at $0.5438. In addition, cbdMD Inc saw 52.69% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for YCBD
Current profitability levels for the company are sitting at:
- -0.17 for the present operating margin
- 0.6 for the gross margin
The net margin for cbdMD Inc stands at -0.24. The total capital return value is set at -1.65. Equity return is now at value -67.31, with -27.64 for asset returns.
Based on cbdMD Inc (YCBD), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at -0.28. The debt to equity ratio resting at 0.65. The interest coverage ratio of the stock is -102.92.
Currently, EBITDA for the company is -1.49 million with net debt to EBITDA at 0.92. When we switch over and look at the enterprise to sales, we see a ratio of 0.12. The receivables turnover for the company is 19.8for trailing twelve months and the total asset turnover is 1.84. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.74.
Conclusion
In conclusion, cbdMD Inc (YCBD) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
